ocThis webpage is dedicated towards providing coronavirus (COVID-19) resources for pharmacists.

Maintained By: Timothy P. Gauthier, Pharm.D., BCPS

Supported By: Bassam Ghanem, Pharm.D., MS, BCPS

DISCLAIMER: Information found on IDstewardship.com is intended to provide information and education and does not represent official views of the Society of Infectious Diseases Pharmacists. Click here to earn free ACPE/BCIDP continuing education credit through a collaboration between SIDP and IDstewardship.com

Created: 14 March 2020

Last updated: 17 September 2020, update #247

Many pharmacists across the world are working hard to keep up with therapeutic options for coronavirus / SARS-CoV-2 / COVID-19. This webpage was created to provide insights and resources for pharmacists helping to manage this pandemic. Take note that updates to the page will be made periodically as permitted and the content here may not be completely up-to-date as the situation is evolving quickly. Also beware that much of the data identified below is of relatively poor quality in terms of utility for determining what should be done in clinical practice.

Additionally, there are many potential COVID-19 therapies, I list several at the bottom, but do not discuss them in depth. Some of these can potentially lessen the cytokine storm associated with COVID-19 and help with managing acute respiratory distress syndrome (ARDS).

MOST IMPORTANTLY: Thus far no antiviral drug has been proven to work against COVID-19 in humans, although many randomized controlled trials are ongoing. There are no drugs or other therapeutics approved by the US Food and Drug Administration to prevent or treat COVID-19. Inclusion in this webpage is not an endorsement for use of any of these drugs for COVID-19.

To see what is new look for the ✓ symbol, we will be adding this to new material and removing it from older material as we keep updating the page. Use CTRL+F and search for it to find what is new.

If you have a resource that is helpful and reliable, but not posted here, send it to me: IDstewardship@gmail.com or @IDstewardship on Twitter.

Special Highlights

General COVID-19 Resources

Institutional, Governmental & Society COVID-19 Treatment Guidelines

COVID-19 Resource Centers

COVID-19 Oriented Data Tracking Resources

COVID-19 Symptom Analysis

General Notes on COVID-19

Vaccine Literature

Remdesivir for COVID-19: Resources & Notes

Hydroxychloroquine/ Chloroquine Resources and Notes for COVID-19

Hydroxychloroquine (Plaquenil) for COVID-19: Resources & Notes

Chloroquine-specific Resources & Notes for COVID-19

Lopinavir/ritonavir (Kaletra, LPV/r) for COVID-19: Resources & Notes

Tocilizumab (Actemra) for COVID-19: Resources & Notes

List of Other Potential Therapies

Anticipated COVID-19 Literature

RECOVERY Trial: Randomized Evaluation of COVID-19 Therapy A study out of the UK investigating numerous potential therapies for COVID-19, some of the data has been released and is cited elsewhere on this webpage



COVID-19 Literature

Other COVID-19 Webpages & Resources

DISCLAIMER: The views expressed in this article represent that of the author and do not necessarily reflect the position or policy of any previous, current, or potential future employers or other organizations in which he serves.

RECOMMENDED TO YOU